New Nordic Healthbrands AB (SE:NNH)
:NNH
Want to see SE:NNH full AI Analyst Report?
Top Page
New Nordic Healthbrands AB
(NNH)
Select Model
Select Model
Rating:52Neutral
Price Target:
kr13.00
▼(-39.53% Downside)
Action:Reiterated
Date:05/04/26
The score is held back primarily by weak technical trend signals (below all major moving averages with negative MACD) and a financial recovery that still features thin margins and volatile cash generation. Valuation is a modest positive with a mid-range P/E and a small dividend yield.
Positive Factors
Manageable leverage and stable equity
A modest debt load and stable equity indicate the company has balance-sheet flexibility to withstand shocks and fund working capital or targeted investments over the next several months. Manageable leverage reduces refinancing risk and preserves options for strategic initiatives.
Negative Factors
Very thin operating and net margins
Extremely narrow margins mean even modest cost inflation, pricing pressure, or mix shifts can erase profits. Low operating leverage constrains the firm's ability to absorb shocks and limits free cash flow expansion, making consistent margin improvement crucial for durable stability.
Read all positive and negative factors
Positive Factors
Negative Factors
Manageable leverage and stable equity
A modest debt load and stable equity indicate the company has balance-sheet flexibility to withstand shocks and fund working capital or targeted investments over the next several months. Manageable leverage reduces refinancing risk and preserves options for strategic initiatives.
Read all positive factors
New Nordic Healthbrands AB (NNH) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr78.68M
Dividend YieldN/A
Average Volume (3M)5.45K
Price to Earnings (P/E)29.8
Beta (1Y)0.28
Revenue Growth0.20%
EPS GrowthN/A
CountrySE
Employees78
SectorConsumer Defensive
Sector Strength42
IndustryMedical - Pharmaceuticals
Share Statistics
EPS (TTM)0.43
Shares Outstanding6,195,200
10 Day Avg. Volume3,153
30 Day Avg. Volume5,451
Financial Highlights & Ratios
PEG Ratio-0.09
Price to Book (P/B)1.39
Price to Sales (P/S)0.25
P/FCF Ratio18.98
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
New Nordic Healthbrands AB Business Overview & Revenue Model
Company Description
New Nordic Healthbrands AB (publ)., engages in providing dietary supplements, natural medicines and cosmetic products for various health and beauty needs in the Nordic countries, Europe, North America, and internationally. The company provides vit...
How the Company Makes Money
null...
New Nordic Healthbrands AB Financial Statement Overview
Summary
Income Statement
54
Neutral
Balance Sheet
67
Positive
Cash Flow
46
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 565.03M | 576.36M | 550.31M | 533.85M | 487.50M | 514.85M |
| Gross Profit | 181.72M | 15.95M | 354.69M | 348.23M | 318.50M | 350.05M |
| EBITDA | 11.27M | 17.61M | -1.43M | -1.94M | -2.57M | 29.34M |
| Net Income | 2.68M | 8.20M | -7.70M | -6.19M | -2.82M | 21.30M |
Balance Sheet | ||||||
| Total Assets | 264.32M | 246.15M | 248.72M | 249.06M | 251.67M | 238.35M |
| Cash, Cash Equivalents and Short-Term Investments | 8.66M | 16.55M | 15.25M | 13.81M | 10.70M | 11.88M |
| Total Debt | 39.66M | 35.84M | 39.22M | 26.64M | 48.35M | 24.43M |
| Total Liabilities | 162.35M | 142.69M | 148.19M | 143.03M | 139.10M | 118.03M |
| Stockholders Equity | 101.97M | 103.47M | 100.92M | 106.03M | 112.57M | 120.32M |
Cash Flow | ||||||
| Free Cash Flow | 2.00M | 7.57M | -6.62M | 25.88M | -18.41M | -10.58M |
| Operating Cash Flow | 3.78M | 8.39M | -5.40M | 28.03M | -15.45M | -7.87M |
| Investing Cash Flow | -4.73M | -3.22M | -3.71M | -3.40M | -2.62M | -2.97M |
| Financing Cash Flow | 1.16M | -3.38M | 10.39M | -21.17M | 16.59M | 12.07M |
New Nordic Healthbrands AB Technical Analysis
Negative
21.50
Price Trends
15.63
Negative
16.53
Negative
19.26
Negative
Market Momentum
-0.74
Negative
33.83
Neutral
20.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:NNH, the sentiment is Negative. The current price of 21.5 is above the 20-day moving average (MA) of 13.62, above the 50-day MA of 15.63, and above the 200-day MA of 19.26, indicating a bearish trend. The MACD of -0.74 indicates Negative momentum. The RSI at 33.83 is Neutral, neither overbought nor oversold. The STOCH value of 20.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:NNH.
New Nordic Healthbrands AB Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | kr1.61B | 23.35 | ― | 4.05% | 10.90% | 54.98% | |
69 Neutral | kr1.99B | 23.22 | -0.17% | 2.34% | -3.99% | 123.69% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | kr566.50M | 47.25 | ― | 2.43% | -10.22% | -19.59% | |
55 Neutral | kr3.33B | 98.03 | 0.87% | ― | 4.55% | -71.28% | |
54 Neutral | kr450.21M | 17.15 | ― | 0.51% | 24.64% | 136.01% | |
52 Neutral | kr78.68M | 29.77 | ― | ― | 0.20% | ― |
* Consumer Defensive Sector Average
SE:NNH
New Nordic Healthbrands AB
12.80
-6.34
-33.12%
SE:MSON.B
Midsona AB Class B
13.70
5.05
58.45%
SE:HUMBLE
Humble Group AB
6.97
-1.39
-16.63%
SE:SKMO
Skane-moellan AB
51.50
-14.17
-21.58%
SE:CHEF
Cheffelo AB
121.20
75.77
166.81%
SE:SNX
Premium Snacks Nordic AB
33.45
6.91
26.05%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.